Literature DB >> 20041096

Major clinical research advances in gynecologic cancer 2009.

Kidong Kim1, Sang-Young Ryu.   

Abstract

In this review, we summarized nine major clinical advances in gynecology which occurred in 2009. For cervical cancer, the role of human papillomavirus (HPV) test as a screening test, the efficacy of HPV vaccine for middle-aged women, randomized controlled trial (RCT) regarding concurrent chemoradiation using gemcitabine plus cisplatin, and the efficacy of pazopanib for metastatic or recurrent disease were chosen. For endometrial cancer, the necessity of systematic pelvic lymphadenectomy in early endometrial cancer was reviewed. For ovarian cancer, the timing of treatment initiation for recurrent ovarian cancer, dose-dense chemotherapy as postoperative adjuvant treatment, the best chemotherapy regimen for platinum-sensitive recurrent ovarian cancer, and the efficacy of target agents were selected. In addition, the results of RCT testing the benefit of ginger in preventing post-chemotherapy nausea were examined.

Entities:  

Keywords:  Biomedical research; Gynecology; Urogenital neoplasms

Year:  2009        PMID: 20041096      PMCID: PMC2799016          DOI: 10.3802/jgo.2009.20.4.203

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  38 in total

1.  Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup.

Authors:  I Vergote; G J Rustin; E A Eisenhauer; G B Kristensen; E Pujade-Lauraine; M K Parmar; M Friedlander; A Jakobsen; J B Vermorken
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

Review 2.  Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).

Authors:  G R Morrow; J T Hickok; S N Rosenthal
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

3.  The role of CA 125 and conventional examinations in diagnosing progressive carcinoma of the ovary.

Authors:  M E van der Burg; F B Lammes; J Verweij
Journal:  Surg Gynecol Obstet       Date:  1993-04

4.  Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.

Authors:  Bradley J Monk; Luis Mas Lopez; Juan J Zarba; Ana Oaknin; Carole Tarpin; Wichai Termrungruanglert; Jacquelyn A Alber; Jie Ding; Melissa W Stutts; Lini N Pandite
Journal:  J Clin Oncol       Date:  2010-07-06       Impact factor: 44.544

5.  Anticipatory anxiety in women receiving chemotherapy for breast cancer.

Authors:  P B Jacobsen; D H Bovbjerg; W H Redd
Journal:  Health Psychol       Date:  1993-11       Impact factor: 4.267

6.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

7.  Major clinical research advances in gynecologic cancer 2008.

Authors:  Kidong Kim; Seok-Cheol Choi; Sang-Young Ryu; Jae Weon Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401

8.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272

9.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  6 in total

1.  Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

Authors:  Si Won Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Wine drinking and epithelial ovarian cancer risk: a meta-analysis.

Authors:  Hee Seung Kim; Jae Weon Kim; Leo J Shouten; Susanna C Larsson; Hyun Hoon Chung; Yong Beom Kim; Woong Ju; Noh Hyun Park; Yong Sang Song; Seung Cheol Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

3.  Major clinical research advances in gynecologic cancer in 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Kidong Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

4.  Major clinical research advances in gynecologic cancer in 2012.

Authors:  Dong Hoon Suh; Jae-Weon Kim; Kidong Kim; Hak Jae Kim; Kyung-Hun Lee
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

Review 5.  Major clinical research advances in gynecologic cancer in 2016: 10-year special edition.

Authors:  Dong Hoon Suh; Miseon Kim; Kidong Kim; Hak Jae Kim; Kyung Hun Lee; Jae Weon Kim
Journal:  J Gynecol Oncol       Date:  2017-03-24       Impact factor: 4.401

6.  Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer.

Authors:  Chel Hun Choi; Tae Heung Kang; Joon Seon Song; Young Seob Kim; Eun Joo Chung; Kris Ylaya; Seokho Kim; Sang Seok Koh; Joon-Yong Chung; Jae-Hoon Kim; Stephen M Hewitt
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.